These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11996795)

  • 1. Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence.
    Tsukamoto M; Matsuyama H; Oba K; Yoshihiro S; Takahashi M; Naito K
    Cancer Genet Cytogenet; 2002 Apr; 134(1):41-5. PubMed ID: 11996795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
    Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
    Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer.
    Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K
    Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence.
    Jung I; Reeder JE; Cox C; Siddiqui JF; O'Connell MJ; Collins L; Yang Z; Messing EM; Wheeless LL
    J Urol; 1999 Dec; 162(6):1900-3. PubMed ID: 10569533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients.
    Panani AD; Babanaraki A; Malianga E; Roussos Ch
    Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
    Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
    J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal aberrations in early-stage bilharzial bladder cancer.
    Aly MS; Khaled HM
    Cancer Genet Cytogenet; 2002 Jan; 132(1):41-5. PubMed ID: 11801307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer.
    Matsuyama H; Bergerheim US; Nilsson I; Pan Y; Skoog L; Tribukait B; Ekman P
    Cancer Genet Cytogenet; 1994 Oct; 77(2):118-24. PubMed ID: 7954321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
    Eleuteri P; Grollino MG; Pomponi D; De Vita R
    Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.
    Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH
    Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
    Neuhaus M; Wagner U; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Moch H; Mihatsch MJ; Gasser TC; Sauter G
    Hum Pathol; 1999 Jan; 30(1):81-6. PubMed ID: 9923932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.
    Marano A; Pan Y; Li C; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
    Eur Urol; 2000 Mar; 37(3):358-65. PubMed ID: 10720866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
    Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
    Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH.
    Sauter G; Gasser TC; Moch H; Richter J; Jiang F; Albrecht R; Novotny H; Wagner U; Bubendorf L; Mihatsch MJ
    Urol Res; 1997; 25 Suppl 1():S37-43. PubMed ID: 9079755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent in situ hybridization as a predictor of relapse in urothelial carcinoma.
    García-Peláez B; Trias I; Román R; Pubill C; Banús JM; Puig X
    Actas Urol Esp; 2013; 37(7):395-400. PubMed ID: 23453297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrations of chromosomes 9 and 17 in bilharzial bladder cancer as detected by fluorescence in situ hybridization.
    Ghaleb AH; Pizzolo JG; Melamed MR
    Am J Clin Pathol; 1996 Aug; 106(2):234-41. PubMed ID: 8712180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
    Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
    J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.